Host Keith Shaw and his expert guests discuss the latest technology news and trends happening in the industry. Watch new episodes twice each week or listen to the podcast here.

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

“Beneficiaries should have access to their full benefits by the end of the day on Friday, Nov. 7,” the Kansas Department for Children and Families posted on its website Friday.